US Broker Ratings

Liquidia Corporation (LQDA): Investor Outlook on a Biotech with 39.68% Potential Upside

Liquidia Corporation (NASDAQ: LQDA), a promising biopharmaceutical entity in the biotechnology sector, is capturing investor attention with its significant potential upside of 39.68%. Headquartered in Morrisville, North Carolina, Liquidia is..

Bausch Health Companies Inc. (BHC) Stock Analysis: Navigating Challenges with Strategic Diversification

Investors in Bausch Health Companies Inc. (NYSE: BHC) find themselves at a crossroads as the company presents a mixed bag of financial metrics and growth opportunities. With a market cap..

Immunovant, Inc. (IMVT) Stock Analysis: A 165% Upside Potential in the Biotech Arena

Immunovant, Inc. (IMVT), a clinical-stage immunology company, is drawing significant attention from investors with its recent stock analysis suggesting a substantial upside potential. With a market capitalization of $2.6 billion..

Evolent Health (EVH) Stock Analysis: Exploring a 57.81% Potential Upside in the Health Information Services Sector

Evolent Health, Inc. (NYSE: EVH) stands as a prominent player in the healthcare sector, specifically within the health information services industry. Based in Arlington, Virginia, Evolent Health leverages its expertise..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Potential 36% Upside Beckons Investors

Establishment Labs Holdings Inc (NASDAQ: ESTA), a prominent name in the healthcare sector, specifically within the medical devices industry, has been drawing considerable attention from investors. Headquartered in the picturesque..

Surgery Partners, Inc. (SGRY) Stock Analysis: Evaluating a Promising 34.55% Upside

For investors with a keen eye on the healthcare sector, Surgery Partners, Inc. (NASDAQ: SGRY) presents an intriguing opportunity. With a market capitalization of $2.95 billion, this Brentwood, Tennessee-based company..

Concentra Group Holdings Parent (CON) Stock Analysis: A Promising Upside of Over 20% in the Healthcare Sector

Concentra Group Holdings Parent, Inc. (CON), a prominent player in the healthcare sector’s medical care facilities industry, is capturing investor attention with its strong market potential and robust growth metrics...

Indivior PLC (INDV) Stock Analysis: Healthcare Innovator with a 13.84% Upside

Indivior PLC (INDV), a prominent player in the healthcare sector, is capturing investor attention with its compelling growth potential and an impressive 13.84% upside according to analyst ratings. Operating within..

Schrodinger, Inc. (SDGR) Investor Outlook: Analyzing the 39.71% Potential Upside

For investors with an eye on the healthcare sector, Schrödinger, Inc. (NASDAQ: SDGR) presents a fascinating opportunity. Positioned within the Health Information Services industry, this New York-based company operates at..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Strong Buy Ratings Amid Promising Revenue Growth

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a Canadian biopharmaceutical company, is making noticeable waves in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $1.6 billion, Aurinia..

Teladoc Health, Inc. (TDOC) Stock Analysis: Is There a Potential 18.97% Upside for Investors?

As the healthcare industry continues to embrace digital transformation, Teladoc Health, Inc. (NYSE: TDOC) stands at the forefront, offering innovative virtual healthcare services worldwide. However, with recent financial metrics posing..

Veracyte, Inc. (VCYT) Stock Analysis: A Diagnostic Powerhouse with 34.52% Potential Upside

Veracyte, Inc. (NASDAQ: VCYT), a leader in the diagnostics and research industry, is capturing investor attention with its robust product offerings and significant growth potential. Headquartered in South San Francisco,..

Celldex Therapeutics, Inc. (CLDX): Investor Outlook with a 153% Potential Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX), headquartered in Hampton, New Jersey, stands out in the biotechnology industry with its innovative approach to tackling severe inflammatory, allergic, and autoimmune diseases. Specializing in..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Navigating a Potential 1.69% Upside in the Healthcare Sector

Aveanna Healthcare Holdings Inc (AVAH) stands as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry in the United States. With a market cap of..

Integra LifeSciences Holdings (IART) Stock Analysis: Navigating Challenges with a Potential 11.25% Upside

Integra LifeSciences Holdings C (NASDAQ: IART) is a notable player in the healthcare sector, specializing in the manufacture and distribution of medical devices. With a market capitalization of $1.11 billion,..

Xenon Pharmaceuticals Inc. (XENE): Analyst Consensus Reveals 43.92% Potential Upside in Neuroscience Biotech

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a prominent player in the biotechnology sector, is capturing attention with its promising pipeline in neuroscience therapeutics and a compelling 43.92% potential upside based on..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a Potential 33% Upside Amidst Strong Analyst Ratings

NeoGenomics, Inc. (NASDAQ: NEO), a leader in the healthcare sector specializing in diagnostics and research, is capturing investor attention with a notable potential upside of 33.51%, according to recent analyst..

Biohaven Ltd. (BHVN) Stock Analysis: A Look at the 215% Potential Upside

Biohaven Ltd. (NASDAQ: BHVN), a dynamic player in the healthcare sector specializing in biotechnology, is capturing investors’ attention with its impressive 215.55% potential upside. With a market cap of $1.58..

Opko Health, Inc. (OPK)

⚠️ No article content returned.

..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Unpacking the 243% Upside Potential

Viking Therapeutics, Inc. (NASDAQ: VKTX), a dynamic player in the biotechnology sector, is capturing the attention of investors with its innovative approach to treating metabolic and endocrine disorders. Headquartered in..

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds